The balance between ER stress–mediated cardiomyocyte survival and ER stress–mediated cardiomyocyte apoptosis is a critical factor that directs the protective effect of Tbx20, and it must be taken into account while considering therapeutic approaches to ER stress–mediated cardiomyopathies. Here, TBX20 is linked to cardiomyopathy.